ArticleFrontiers in oncology2025

Case Report: Trastuzumab deruxtecan plus toripalimab in ERBB2-amplified cervical mucosal melanoma.

Xiao-Xia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.